CHAMBER HILL STRATEGIES for SAGHMOS THERAPEUTICS, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the policies proposed in the 21st Century Cures 2.0 Concept Paper. Education and awareness, generally, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention. Education regarding outpatient treatment protocols for at home care of COVID-19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BARTLETT | Counsel, U.S. House of Representatives, Committee on Energy and Commerce |
| JENNIFER BELL | Health Policy Advisor, Sen. Finance Committee |
| ANNA KATHERINE WEINSTEIN | — |
Medicare/Medicaid MMM
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BARTLETT | Counsel, U.S. House of Representatives, Committee on Energy and Commerce |
| JENNIFER BELL | Health Policy Advisor, Sen. Finance Committee |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.